logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5137.produseast1
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis | Conference Material / Video | MSF Science Portal
Conference Material
|Video

Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis

Berry C
Similar Content
Abstract
|Abstract
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research
Slide Presentation
|Slide Presentation
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research
Loading...

Countries

Belarus South Africa Uzbekistan

Subject Area

antibiotic resistancetuberculosisantimicrobial resistance

Languages

English
Published Date
19 May 2021
Conference
MSF Scientific Days International 2021: Research
Linked Content
Conference Material
|Abstract
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research
Conference Material
|Slide Presentation
Early termination of randomisation into TB-PRACTECAL, a study examining novel six month, all-oral regimens for treatment of drug-resistant tuberculosis
2021 May 19 • MSF Scientific Days International 2021 Research